{"canonical":"https://abierto.us/vendors/abviro-llc-k3l6kxj9b6m7","key":"K3L6KXJ9B6M7","name":"ABVIRO LLC","uei":"K3L6KXJ9B6M7","city":"BETHESDA","state":"MD","awards":2,"obligated":"9318256.92","notices_won":0,"top_agency_name":"National Institutes of Health","top_naics":"541715","cage":"75YF3","parent_name":"ABVIRO LLC","also_known_as":[],"country":"USA","actions":8,"first_action":"2024-02-14","last_action":"2026-03-24","breakdowns":{"naics":[{"key":"541715","name":null,"awards":1,"obligated":"9582135.00"},{"key":"541711","name":null,"awards":1,"obligated":"-263878.08"}],"places":[{"key":"MD","name":null,"awards":2,"obligated":"9318256.92"}],"agencies":[{"key":"7529","name":"National Institutes of Health","awards":2,"obligated":"9318256.92"}],"award_types":[{"key":"DEFINITIVE CONTRACT","name":null,"awards":2,"obligated":"9318256.92"}],"competition":[{"key":"FULL AND OPEN COMPETITION","name":null,"awards":2,"obligated":"9318256.92"}],"product_service_codes":[{"key":"AN12","name":null,"awards":2,"obligated":"9318256.92"}]},"awards_list":[{"award_key":"CONT_AWD_75N93023C00055_7529_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N93023C00055_7529_-NONE-_-NONE-/","piid":"75N93023C00055","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"K3L6KXJ9B6M7","recipient_name":"ABVIRO LLC","recipient_uei":"K3L6KXJ9B6M7","recipient_cage":"75YF3","recipient_city":"BETHESDA","recipient_state":"MD","sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NIAID","office_key":"o-75N930","first_action_date":"2024-02-14","last_action_date":"2026-03-24","actions":6,"obligated":"9582135.00","current_total_value":"11335102.00","potential_total_value":"12356811.00","naics":"541715","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":31,"description":"TO CONDUCT A PHASE 2 DENGUE HUMAN CHALLENGE CLINICAL TRIAL OF ABVIRO ANTI-DENGUE MONOCLONAL ANTIBODY (MAB) AV-1.","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_HHSN272201600028C_7529_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_HHSN272201600028C_7529_-NONE-_-NONE-/","piid":"HHSN272201600028C","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"K3L6KXJ9B6M7","recipient_name":"ABVIRO LLC","recipient_uei":"K3L6KXJ9B6M7","recipient_cage":"75YF3","recipient_city":"BETHESDA","recipient_state":"MD","sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NIAID","office_key":"o-75N930","first_action_date":"2024-09-13","last_action_date":"2025-09-23","actions":2,"obligated":"-263878.08","current_total_value":"29175011.23","potential_total_value":"29175011.23","naics":"541711","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":13,"description":"THE PURPOSE OF THIS CONTRACT IS TO DEVELOP A MONOCLONAL ANTIBODY (MAB) AV-1 AS A SAFE INJECTABLE THERAPEUTIC.","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null}],"awards_total":2,"awards_page":1,"won":[],"won_total":0,"solicitations_won":[]}